Nuclear Localization of the DOCK180/ELMO Complex

Total Page:16

File Type:pdf, Size:1020Kb

Nuclear Localization of the DOCK180/ELMO Complex ABB Archives of Biochemistry and Biophysics 429 (2004) 23–29 www.elsevier.com/locate/yabbi Nuclear localization of the DOCK180/ELMO complex Jinhu Yin,a Lisa Haney,b Scott Walk,b Sharleen Zhou,c Kodi S. Ravichandran,b and Weidong Wanga,* a Laboratory of Genetics, National Institute on Aging, National Institutes of Health, Baltimore, MA 21224, USA b Beirne Carter Center for Immunology Research and the Department of Microbiology, University of Virginia, Charlottesville, VA 22908, USA c Howard Hughes Medical Institute, University of California, Berkeley, CA 94720, USA Received 19 March 2004, and in revised form 18 May 2004 Available online 2 July 2004 Abstract DOCK180 protein plays a key role during development, cell motility, and phagocytosis. It forms a complex with another protein ELMO, and this complex acts as a guanine nucleotide exchange factor (GEF) for Rac. However, DOCK180-con- taining complexes have not been purified by unbiased biochemical approaches, and the nature and subcellular localization of these complexes remain unclear. Here, we show that a large fraction of endogenous DOCK180 is present as a 700 kDa nuclear complex with ELMO proteins. In addition, this nuclear DOCK180/ELMO complex has functional Rac-GEF activity. Furthermore, endogenous DOCK180 could be found in complexes with different ELMO isoforms (ELMO1, 2 or 3) in different cell lines, depending on the ELMO isoforms expressed. These studies suggest that DOCK180 may associate with different ELMO proteins to form cell-type specific complexes and may have functions in both the nucleus and the cyto- plasm. Ó 2004 Elsevier Inc. All rights reserved. Keywords: DOCK180; ELMO; Guanine nucleotide exchange factor; Molecular complex; Nuclear localization Mammalian DOCK180 protein and its homologues nucleotide exchange factors (GEFs)1 [16–18], DOCK180 in Drosophila Myoblast City and Caenorhabditis elegans contains a novel domain, termed Docker domain, which (CED-5) represent an evolutionarily conserved family of specifically recognizes nucleotide-free Rac and can proteins involved in multiple biological processes. promote loading of GTP by Rac in vitro [19]. Recent DOCK180 participates in actin cytoskeletal changes evidences suggest that in addition to Dock180, 10 ad- during cell migration and phagocytosis of apoptotic cells ditional proteins in the human genome contain a Docker [1–6]. The Drosophila (Myoblast City) plays a role in domain, and that these constitute a Dock180 super- myoblast fusion, dorsal closure, and cytoskeletal orga- family of proteins [20]. These different DOCK180 family nization during embryonic development [7–9]. The C. members have been linked to various biological pro- elegans CED-5 is implicated in engulfment of cell cesses including cell adhesion, migration, phagocytosis corpses and in distal tip cell migration [5,10–15]. The of apoptotic cells, and tumor cell metastasis. DOCK180 family of proteins has been suggested to Several lines of evidence have suggested that function as an upstream regulator of the small GTPase DOCK180 forms a complex with another protein Rac, which mediates membrane ruffling and other cy- ELMO1 [5,19], which, like DOCK180, has also been toskeletal changes [8,10]. Although DOCK180 does not identified as an evolutionarily conserved upstream contain the conventional Dbl homology (DH) domain found in essentially all known mammalian Rac guanine 1 Abbreviations used: DTT, dithiothreitol; ELMO, engulfment and cell motility; GEF, guanine nucleotide exchange factor; IP, immuno- * Corresponding author. Fax: 1-410-558-8331. precipitation; PMSF, phenylmethylsulfonyl fluoride; SDS–PAGE, E-mail address: [email protected] (W. Wang). sodium dodecyl sulfate–polyacrylamide gel electrophoresis. 0003-9861/$ - see front matter Ó 2004 Elsevier Inc. All rights reserved. doi:10.1016/j.abb.2004.05.014 24 J. Yin et al. / Archives of Biochemistry and Biophysics 429 (2004) 23–29 regulator of Rac. CED-12, the ELMO1 homologue in (DTT), 0.2 mM phenylmethylsulfonyl fluoride (PMSF), C. elegans, has been shown to function genetically at 2 lg/ml leupeptin, and 2 lg/ml aprotinin). The mixture the same step as DOCK180/CED-5 in engulfment of was incubated with 2 lg of DOCK180 antibodies in the apoptotic cells and cell migration in nematodes presence of 100 ll of protein A-beads (Amersham– [5,10,13,14]. In cell culture studies, DOCK180 itself is Pharmacia) for at least 12 h at 4 °C. The immunopre- insufficient for GTP loading of Rac, and a complex with cipitate was washed three times with the IP buffer. The ELMO is required [19]. Recent studies indicate that the complex on the beads was either used in the GEF assay DOCK180/ELMO complex functions as a bi-partite or was eluted from the beads using 100 mM glycine–HCl GEF for Rac [19,21]. At least three ELMO proteins buffer (pH2.5). The eluted complex was subjected to (ELMO1, 2, and 3) have been reported in mammals, and sodium dodecyl sulfate–polyacrylamide gel electropho- none of them contains any obvious catalytic domains. resis (SDS–PAGE) and immunoblotting analysis. Less Although endogenous DOCK180 and ELMO1 have than 10% of the input was loaded as control for im- been shown to occur as a complex in cells [19], this munoblotting. For mass spectrometric analysis, the complex has not been purified by unbiased biochemical proteins were visualized by Coomassie blue staining, approaches. Thus, the nature of the DOCK180/ELMO excised from the gel, and digested with trypsin. The complex, and its localization remain unclear. Here, we peptides obtained were analyzed by matrix-assisted laser have immunoisolated DOCK180-containing complexes desorption ionization-time of flight mass spectrometry. from several mammalian cell lines. We show that DOCK180 is present in a complex with ELMO in both Nuclear extract fractionation the nucleus and the cytoplasm, and that DOCK180 can form complexes with multiple ELMO isoforms in dif- The HeLa S3 nuclear or cytoplasmic extract was di- ferent cell lines. rectly applied to a Superose 6 column (HR16/50; Amersham) equilibrated with the column running buffer containing 20 mM Hepes (pH 7.9), 200 mM NaCl, 1 mM Experimental procedures DTT, 0.1 mM PMSF, 5 lg/ml leupeptin, and 5% glyc- erol. Fractions were collected and analyzed by SDS– Cells and antibodies PAGE and immunoblotting. HeLa S3 and CHO-K1 cells were obtained from In vitro GEF assay the National Cell Culture Center. Nuclear and cyto- plasmic extracts were prepared as previously described The DOCK180 complex immobilized on the protein [22]. Three DOCK180 antibodies (sc-5635, sc-13163, A beads was analyzed for Rac GEF activity as follows and sc-6167) were obtained from Santa Cruz Bio- [19]: 1 lg of bacterially expressed and purified Rac was technology. Another DOCK180 antibody was kindly incubated with 50 lCi of [a-32P]GTP (3000 Ci/mmol) in provided by Dr. Matsuda (Japan). The ELMO1 an- a loading buffer containing 40 mM Mops (pH 7.1), tibody has been described previously [19], which has 1 mM EDTA, 1 mg/ml BSA, and 0.3 lM unlabeled weak cross-reactivity to ELMO2. The rabbit ELMO2 GTP, for 20 min on ice. Magnesium chloride was then antibody was generated against a recombinant GST– added at a final concentration of 10 mM, and the mix- ELMO2 fusion protein (encompassing amino acid ture was incubated on ice for an additional 10 min. residues 1–551 of ELMO2) expressed in E. coli. The [a-32P]GTP-loaded Rac (50 ng) was added to the specific reactivity of the ELMO2 antibody was con- DOCK180 complex, and the mixture was diluted using firmed using ELMO1, ELMO2, and ELMO3 proteins an exchange buffer containing 25 mM Mops (pH 7.1), expressed in 293T cells, as well as bacterially produced 6.25 mM magnesium chloride, 0.6 mM NaH2PO4, recombinant proteins (data not shown). The ELMO2 0.5 mg/ml BSA, and 1.25 mM GDP (unlabeled), so that antibody was purified on a protein-A column prior to the final volume was 100 ll. After 15-min incubation at use in immunoblotting. 30 °C, 50 ll of the exchange reaction was subjected to filter binding to nitrocellulose and scintillation counting. Immunoisolation of DOCK180 complexes The presence of GEF-activity was detected by loss of radioactivity bound to Rac (as a result of the exchange DOCK180 complexes were isolated from both nu- reaction). [32P]GTP bound to Rac when incubated with clear and cytoplasmic extracts of HeLa and CHO-K1 the exchange buffer alone was set at 100%. The data cells by using an immunoprecipitation protocol previ- presented are representatives of at least three indepen- ously described (Lee et al. unpublished data; [23]). dent experiments. In a time course of this exchange as- Briefly, 1 ml (7 mg/ml) of nuclear extract was diluted 10 say with the DOCK180 complex, the maximal exchange fold with IP buffer (20 mM Hepes [pH 7.9], 200 mM on Rac was detected between 10 and 20 min. Hence, a NaCl, 10% glycerol, 0.1% NP-40, 1 mM dithiothreitol 15-min point was chosen for the assay. J. Yin et al. / Archives of Biochemistry and Biophysics 429 (2004) 23–29 25 Immunofluorescence In contrast, although nucleotide-free Rac, p130Cas and CrkII have been shown to interact with DOCK180 [1– Cell fixation and blocking followed a published pro- 5], we failed to detect these proteins as part of the tocol [24]. Cells were incubated with a DOCK180 anti- DOCK180 complex (data not shown), implying that the body (Santa Cruz Biotechnology) in blocking buffer (5% interactions between these polypeptides and DOCK180 milk in PBS with 0.2% Triton X-100) at 4 °C overnight, are not stable enough to withstand the isolation proce- and then stained with Alexa Fluor 568-conjugated sec- dure used here. ondary antibody (Molecular Probes). DNA was stained Superose 6 gel-filtration fractionation revealed that using the TOTO-3 dye (Molecular Probes).
Recommended publications
  • Small Cell Ovarian Carcinoma: Genomic Stability and Responsiveness to Therapeutics
    Gamwell et al. Orphanet Journal of Rare Diseases 2013, 8:33 http://www.ojrd.com/content/8/1/33 RESEARCH Open Access Small cell ovarian carcinoma: genomic stability and responsiveness to therapeutics Lisa F Gamwell1,2, Karen Gambaro3, Maria Merziotis2, Colleen Crane2, Suzanna L Arcand4, Valerie Bourada1,2, Christopher Davis2, Jeremy A Squire6, David G Huntsman7,8, Patricia N Tonin3,4,5 and Barbara C Vanderhyden1,2* Abstract Background: The biology of small cell ovarian carcinoma of the hypercalcemic type (SCCOHT), which is a rare and aggressive form of ovarian cancer, is poorly understood. Tumourigenicity, in vitro growth characteristics, genetic and genomic anomalies, and sensitivity to standard and novel chemotherapeutic treatments were investigated in the unique SCCOHT cell line, BIN-67, to provide further insight in the biology of this rare type of ovarian cancer. Method: The tumourigenic potential of BIN-67 cells was determined and the tumours formed in a xenograft model was compared to human SCCOHT. DNA sequencing, spectral karyotyping and high density SNP array analysis was performed. The sensitivity of the BIN-67 cells to standard chemotherapeutic agents and to vesicular stomatitis virus (VSV) and the JX-594 vaccinia virus was tested. Results: BIN-67 cells were capable of forming spheroids in hanging drop cultures. When xenografted into immunodeficient mice, BIN-67 cells developed into tumours that reflected the hypercalcemia and histology of human SCCOHT, notably intense expression of WT-1 and vimentin, and lack of expression of inhibin. Somatic mutations in TP53 and the most common activating mutations in KRAS and BRAF were not found in BIN-67 cells by DNA sequencing.
    [Show full text]
  • A Rac/Cdc42 Exchange Factor Complex Promotes Formation of Lateral filopodia and Blood Vessel Lumen Morphogenesis
    ARTICLE Received 1 Oct 2014 | Accepted 26 Apr 2015 | Published 1 Jul 2015 DOI: 10.1038/ncomms8286 OPEN A Rac/Cdc42 exchange factor complex promotes formation of lateral filopodia and blood vessel lumen morphogenesis Sabu Abraham1,w,*, Margherita Scarcia2,w,*, Richard D. Bagshaw3,w,*, Kathryn McMahon2,w, Gary Grant2, Tracey Harvey2,w, Maggie Yeo1, Filomena O.G. Esteves2, Helene H. Thygesen2,w, Pamela F. Jones4, Valerie Speirs2, Andrew M. Hanby2, Peter J. Selby2, Mihaela Lorger2, T. Neil Dear4,w, Tony Pawson3,z, Christopher J. Marshall1 & Georgia Mavria2 During angiogenesis, Rho-GTPases influence endothelial cell migration and cell–cell adhesion; however it is not known whether they control formation of vessel lumens, which are essential for blood flow. Here, using an organotypic system that recapitulates distinct stages of VEGF-dependent angiogenesis, we show that lumen formation requires early cytoskeletal remodelling and lateral cell–cell contacts, mediated through the RAC1 guanine nucleotide exchange factor (GEF) DOCK4 (dedicator of cytokinesis 4). DOCK4 signalling is necessary for lateral filopodial protrusions and tubule remodelling prior to lumen formation, whereas proximal, tip filopodia persist in the absence of DOCK4. VEGF-dependent Rac activation via DOCK4 is necessary for CDC42 activation to signal filopodia formation and depends on the activation of RHOG through the RHOG GEF, SGEF. VEGF promotes interaction of DOCK4 with the CDC42 GEF DOCK9. These studies identify a novel Rho-family GTPase activation cascade for the formation of endothelial cell filopodial protrusions necessary for tubule remodelling, thereby influencing subsequent stages of lumen morphogenesis. 1 Institute of Cancer Research, Division of Cancer Biology, 237 Fulham Road, London SW3 6JB, UK.
    [Show full text]
  • Nº Ref Uniprot Proteína Péptidos Identificados Por MS/MS 1 P01024
    Document downloaded from http://www.elsevier.es, day 26/09/2021. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited. Nº Ref Uniprot Proteína Péptidos identificados 1 P01024 CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 por 162MS/MS 2 P02751 FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 131 3 P01023 A2MG_HUMAN Alpha-2-macroglobulin OS=Homo sapiens GN=A2M PE=1 SV=3 128 4 P0C0L4 CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 95 5 P04275 VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 81 6 P02675 FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 78 7 P01031 CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 66 8 P02768 ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 66 9 P00450 CERU_HUMAN Ceruloplasmin OS=Homo sapiens GN=CP PE=1 SV=1 64 10 P02671 FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 58 11 P08603 CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 56 12 P02787 TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 54 13 P00747 PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 48 14 P02679 FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 47 15 P01871 IGHM_HUMAN Ig mu chain C region OS=Homo sapiens GN=IGHM PE=1 SV=3 41 16 P04003 C4BPA_HUMAN C4b-binding protein alpha chain OS=Homo sapiens GN=C4BPA PE=1 SV=2 37 17 Q9Y6R7 FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 30 18 O43866 CD5L_HUMAN CD5 antigen-like OS=Homo
    [Show full text]
  • ELMO2 Polyclonal Antibody
    ELMO2 polyclonal antibody Catalog # : PAB6106 規格 : [ 100 ug ] List All Specification Application Image Product Goat polyclonal antibody raised against synthetic peptide of ELMO2. Western Blot (Tissue lysate) Description: Immunogen: A synthetic peptide corresponding to C-terminus of human ELMO2. Sequence: C-PKEPSSYDFVYHYG enlarge Host: Goat Immunohistochemistry Theoretical MW 82.5 (Formalin/PFA-fixed paraffin- (kDa): embedded sections) Reactivity: Human Specificity: NP_877496.1 and NP_57340.3.1 are varients that encode the same protein. enlarge Form: Liquid ELISA Purification: Antigen affinity purification Concentration: 0.5 mg/mL Recommend ELISA (1:32000) Usage: Western blot (1-3 ug/mL) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (3-6 ug/mL) The optimal working dilution should be determined by the end user. Storage Buffer: In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) Storage Store at -20°C. Instruction: Aliquot to avoid repeated freezing and thawing. Note: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. Datasheet: Download Publication Reference 1. CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Gumienny TL, Brugnera E, Tosello-Trampont AC, Kinchen JM, Haney LB, Nishiwaki K, Walk SF, Nemergut ME, Macara IG, Francis R, Schedl T, Qin Y, Van Aelst L, Hengartner MO, Ravichandran KS.Cell. 2001 Oct 5;107(1):27-41. Applications Western Blot (Tissue lysate) Page 1 of 3 2017/2/16 ELMO2 polyclonal antibody (Cat # PAB6106) staining (2 ug/mL) of human brain lysate (RIPA buffer, 30 ug total protein per lane).
    [Show full text]
  • Phagocytosis of Apoptotic Cells Is Regulated by a UNC-73/TRIO-MIG-2/Rhog Signaling Module and Armadillo Repeats of CED-12/ELMO
    Current Biology, Vol. 14, 2208–2216, December 29, 2004, ©2004 Elsevier Ltd. All rights reserved. DOI 10.1016/j.cub.2004.12.029 Phagocytosis of Apoptotic Cells Is Regulated by a UNC-73/TRIO-MIG-2/RhoG Signaling Module and Armadillo Repeats of CED-12/ELMO Colin D. deBakker,1,7 Lisa B. Haney,1,7 mediated Rac activation and cytoskeletal reorgani- Jason M. Kinchen,3 Cynthia Grimsley,1,2 zation. Mingjian Lu,1 Doris Klingele,3 Pei-Ken Hsu,4 Conclusions: The combination of in vitro and in vivo Bin-Kuan Chou,4 Li-Chun Cheng,4 Anne Blangy,5 studies presented here identify two evolutionarily con- John Sondek,6 Michael O. Hengartner,3 Yi-Chun Wu,4 served players in engulfment, TRIO/UNC73 and RhoG/ and Kodi S. Ravichandran1,* MIG-2, and the TRIO → RhoG signaling module is linked 1Department of Microbiology by ELMO/CED-12 to Dock180-dependent Rac activa- Beirne Carter Center for Immunology Research and tion during engulfment. This work also identifies ARM 2 Department of Pharmacology repeats within CED-12/ELMO and their role in linking University of Virginia RhoG and Rac, two GTPases that function in tandem Charlottesville, VA 22908 during engulfment. 3 Institute of Molecular Biology University of Zurich 8057 Zurich, Introduction Switzerland 4 Institute of Molecular and Cellular Biology Engulfment of apoptotic cells is intimately tied to the National Taiwan University apoptotic program and is linked to development, cellular Taipei homeostasis, and wound healing [1–4]. Phagocytes rec- Taiwan ognize and engulf dying cells at an early stage in the 5 Centre de Recherches de Biochimie apoptotic process to prevent leakage of potentially toxic Macromole´ culaire and inflammatory contents from the dying cells [5].
    [Show full text]
  • Supporting Information
    Supporting Information Friedman et al. 10.1073/pnas.0812446106 SI Results and Discussion intronic miR genes in these protein-coding genes. Because in General Phenotype of Dicer-PCKO Mice. Dicer-PCKO mice had many many cases the exact borders of the protein-coding genes are defects in additional to inner ear defects. Many of them died unknown, we searched for miR genes up to 10 kb from the around birth, and although they were born at a similar size to hosting-gene ends. Out of the 488 mouse miR genes included in their littermate heterozygote siblings, after a few weeks the miRBase release 12.0, 192 mouse miR genes were found as surviving mutants were smaller than their heterozygote siblings located inside (distance 0) or in the vicinity of the protein-coding (see Fig. 1A) and exhibited typical defects, which enabled their genes that are expressed in the P2 cochlear and vestibular SE identification even before genotyping, including typical alopecia (Table S2). Some coding genes include huge clusters of miRNAs (in particular on the nape of the neck), partially closed eyelids (e.g., Sfmbt2). Other genes listed in Table S2 as coding genes are [supporting information (SI) Fig. S1 A and C], eye defects, and actually predicted, as their transcript was detected in cells, but weakness of the rear legs that were twisted backwards (data not the predicted encoded protein has not been identified yet, and shown). However, while all of the mutant mice tested exhibited some of them may be noncoding RNAs. Only a single protein- similar deafness and stereocilia malformation in inner ear HCs, coding gene that is differentially expressed in the cochlear and other defects were variable in their severity.
    [Show full text]
  • Transcriptome Analysis of Peripheral Whole Blood Identifies Crucial
    Zheng et al. BMC Medical Genomics (2020) 13:136 https://doi.org/10.1186/s12920-020-00785-y RESEARCH ARTICLE Open Access Transcriptome analysis of peripheral whole blood identifies crucial lncRNAs implicated in childhood asthma Peiyan Zheng1†, Chen Huang2†, Dongliang Leng2, Baoqing Sun1* and Xiaohua Douglas Zhang2,3* Abstract Background: Asthma is a chronic disorder of both adults and children affecting more than 300 million people heath worldwide. Diagnose and treatment for asthma, particularly in childhood asthma have always remained a great challenge because of its complex pathogenesis and multiple triggers, such as allergen, viral infection, tobacco smoke, dust, etc. It is thereby great significant to deeply investigate the transcriptome changes in asthmatic children before and after desensitization treatment, in order that we could identify potential and key mRNAs and lncRNAs which might be considered as useful RNA molecules for observing and supervising desensitization therapy for asthma, which might guide the diagnose and therapy in childhood asthma. Methods: In the present study, we performed a systematic transcriptome analysis based on the deep RNA sequencing of ten asthmatic children before and after desensitization treatment, including identification of lncRNAs using a stringent filtering pipeline, differential expression analysis and network analysis, etc. Results: First, a large number of lncRNAs were identified and characterized. Then differential expression analysis revealed 39 mRNAs and 15 lncRNAs significantly differentially expressed which involved in two biological processes and pathways. A co-expressed network analysis figured out a desensitization-treatment-related module which contains 27 mRNAs and 21 lncRNAs using WGCNA R package. Module analysis disclosed 17 genes associated to asthma at distinct level.
    [Show full text]
  • Complex Analysis of Retroposed Genes' Contribution to Human
    G C A T T A C G G C A T genes Article Complex Analysis of Retroposed Genes’ Contribution to Human Genome, Proteome and Transcriptome Magdalena Regina Kubiak, Michał Wojciech Szcze´sniakand Izabela Makałowska * Institute of Human Biology and Evolution, Faculty of Biology, Adam Mickiewicz University, 61-614 Pozna´n, Poland; [email protected] (M.R.K.); [email protected] (M.W.S.) * Correspondence: [email protected]; Tel.: +48-61-8295835 Received: 7 April 2020; Accepted: 8 May 2020; Published: 12 May 2020 Abstract: Gene duplication is a major driver of organismal evolution. One of the main mechanisms of gene duplications is retroposition, a process in which mRNA is first transcribed into DNA and then reintegrated into the genome. Most gene retrocopies are depleted of the regulatory regions. Nevertheless, examples of functional retrogenes are rapidly increasing. These functions come from the gain of new spatio-temporal expression patterns, imposed by the content of the genomic sequence surrounding inserted cDNA and/or by selectively advantageous mutations, which may lead to the switch from protein coding to regulatory RNA. As recent studies have shown, these genes may lead to new protein domain formation through fusion with other genes, new regulatory RNAs or other regulatory elements. We utilized existing data from high-throughput technologies to create a complex description of retrogenes functionality. Our analysis led to the identification of human retroposed genes that substantially contributed to transcriptome and proteome. These retrocopies demonstrated the potential to encode proteins or short peptides, act as cis- and trans- Natural Antisense Transcripts (NATs), regulate their progenitors’ expression by competing for the same microRNAs, and provide a sequence to lncRNA and novel exons to existing protein-coding genes.
    [Show full text]
  • Transcriptome Analysis of Peripheral Whole Blood Reveals Key Lncrnas Implicated in Childhood Asthma
    Transcriptome analysis of peripheral whole blood reveals key lncRNAs implicated in childhood asthma Peiyan Zheng Guangzhou Medical University Chen Huang University of Macau Dongliang Leng University of Macau Mengjie Feng Department of respiratory diseases, Shenzhen People's Hospital, Shen Zhen Baoqing Sun Guangzhou Medical University Xiaohua Douglas Zhang ( [email protected] ) University of Macau https://orcid.org/0000-0002-2486-7931 Research article Keywords: childhood asthma, deep RNA-sequencing, transcriptome, long non-coding RNAs Posted Date: October 10th, 2019 DOI: https://doi.org/10.21203/rs.2.15948/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/26 Abstract Background Asthma is a chronic disorder of both adults and children affecting more than 300 million people heath worldwide. Diagnose and treatment for asthma, particularly in childhood asthma have always remained a great challenge because of its complex pathogenesis and multiple triggers, such as allergen, viral infection, tobacco smoke, dust, etc. It is thereby essential to explore novel biomarker or target for diagnose and therapy. Results In the present study, we performed a systematic transcriptome analysis based on the deep RNA sequencing of ten asthmatic children before and after desensitization treatment. First, a large number of lncRNAs were identied and characterized. Then a co-expressed network analysis was conducted to explore potential asthma-related lncRNAs using WGCNA R package. Module analysis disclosed 17 genes associated to asthma at distinct level. Subsequent network analysis based on PCC gured out several key lncRNAs related to asthma, i.e., LINC02145, GUSBP2, which probably involves in immune, inammatory response and apoptosis process.
    [Show full text]
  • Array Comparative Genomic Hybridization and Sequencing of 23 Genes in 80 Patients with Myelofibrosis at Chronic Or Acute Phase
    Chronic Myeloproliferative Disorders SUPPLEMENTARY APPENDIX Array comparative genomic hybridization and sequencing of 23 genes in 80 patients with myelofibrosis at chronic or acute phase Mandy Brecqueville, 1,2,3 Jérôme Rey, 1,3,4 Raynier Devillier, 1,2,3,4 Arnaud Guille, 1,2 Rémi Gillet, 1,2,3 José Adélaide, 1,2 Véronique Gelsi-Boyer, 1,2,3,5 Christine Arnoulet, 1,5 Max Chaffanet, 1,2,3 Marie-Joelle Mozziconacci, 1,2,3,5 Norbert Vey, 1,3,4 Daniel Birnbaum, 1,2,3 and Anne Murati 1,2,3,5 1Centre de Recherche en Cancérologie de Marseille, (CRCM), Inserm, U1068, CNRS UMR7258, Marseille; 2Institut Paoli-Calmettes, Département d’Oncologie Moléculaire, Marseille; 3Aix-Marseille Université, UM 105, Marseille; 4Institut Paoli-Calmettes, Département d’Hématologie, Marseille; and 5Institut Paoli-Calmettes, Département de Biopathologie, Marseille, France ©2013 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol.2013.091454 Manuscript received on May 15, 2013. Manuscript accepted on August 23, 2013. Correspondence: [email protected] Supplemental Table 1. Clinical and biological characteristics of 104 MF samples studied by aCGH and DNA sequencing A. Clinical and biological characteristics of 68 chronic MPNs Time from ) ) diagnosis /L /L) Ci JAK2 PB/ DIPSS 9 9 RCT Previous Samples Sex/Age Diagnosis IPSS DIPSS to Karyotype blast Symptoms V617F aCGH BM plus need Therapies sampling (g/dL cells % (m) (x10 (x10 Platelet count count Platelet Hematocrit (%) Hematocrit Leukocyte count count Leukocyte Hemoglobin level level
    [Show full text]
  • Biomedical Informatics
    BIOMEDICAL INFORMATICS Abstract GENE LIST AUTOMATICALLY DERIVED FOR YOU (GLAD4U): DERIVING AND PRIORITIZING GENE LISTS FROM PUBMED LITERATURE JEROME JOURQUIN Thesis under the direction of Professor Bing Zhang Answering questions such as ―Which genes are related to breast cancer?‖ usually requires retrieving relevant publications through the PubMed search engine, reading these publications, and manually creating gene lists. This process is both time-consuming and prone to errors. We report GLAD4U (Gene List Automatically Derived For You), a novel, free web-based gene retrieval and prioritization tool. The quality of gene lists created by GLAD4U for three Gene Ontology terms and three disease terms was assessed using ―gold standard‖ lists curated in public databases. We also compared the performance of GLAD4U with that of another gene prioritization software, EBIMed. GLAD4U has a high overall recall. Although precision is generally low, its prioritization methods successfully rank truly relevant genes at the top of generated lists to facilitate efficient browsing. GLAD4U is simple to use, and its interface can be found at: http://bioinfo.vanderbilt.edu/glad4u. Approved ___________________________________________ Date _____________ GENE LIST AUTOMATICALLY DERIVED FOR YOU (GLAD4U): DERIVING AND PRIORITIZING GENE LISTS FROM PUBMED LITERATURE By Jérôme Jourquin Thesis Submitted to the Faculty of the Graduate School of Vanderbilt University in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE in Biomedical Informatics May, 2010 Nashville, Tennessee Approved: Professor Bing Zhang Professor Hua Xu Professor Daniel R. Masys ACKNOWLEDGEMENTS I would like to express profound gratitude to my advisor, Dr. Bing Zhang, for his invaluable support, supervision and suggestions throughout this research work.
    [Show full text]
  • The Glomerular Transcriptome and a Predicted Protein–Protein Interaction Network
    BASIC RESEARCH www.jasn.org The Glomerular Transcriptome and a Predicted Protein–Protein Interaction Network Liqun He,* Ying Sun,* Minoru Takemoto,* Jenny Norlin,* Karl Tryggvason,* Tore Samuelsson,† and Christer Betsholtz*‡ *Division of Matrix Biology, Department of Medical Biochemistry and Biophysics, and ‡Department of Medicine, Karolinska Institutet, Stockholm, and †Department of Medical Biochemistry, Go¨teborg University, Go¨teborg, Sweden ABSTRACT To increase our understanding of the molecular composition of the kidney glomerulus, we performed a meta-analysis of available glomerular transcriptional profiles made from mouse and man using five different methodologies. We generated a combined catalogue of glomerulus-enriched genes that emerged from these different sources and then used this to construct a predicted protein–protein interaction network in the glomerulus (GlomNet). The combined glomerulus-enriched gene catalogue provides the most comprehensive picture of the molecular composition of the glomerulus currently available, and GlomNet contributes an integrative systems biology approach to the understanding of glomerular signaling networks that operate during development, function, and disease. J Am Soc Nephrol 19: 260–268, 2008. doi: 10.1681/ASN.2007050588 Many kidney diseases and, importantly, approxi- nins have been shown to be mutated in Alport syn- mately two thirds of all cases of ESRD originate with drome and Pierson congenital nephrotic syndromes, glomerular disease. Most cases of glomerular disease respectively.11,12 Genetic studies in mice have further are caused by systemic disorders (e.g., diabetes, hyper- revealed genes and proteins of importance for glomer- tension, lupus, obesity) for which the molecular ulus development and function, such as podoca- pathogeneses of the glomerular complications are un- lyxin,13 CD2AP,14 NEPH1,15 FAT1,16 forkhead box known.
    [Show full text]